The Role of NF-κB in Physiological Bone Development and Inflammatory Bone Diseases: Is NF-κB Inhibition “Killing Two Birds with One Stone”?

Abstract

Nuclear factor-κB (NF-κB) is a transcription factor that regulates the expression of various genes involved in inflammation and the immune response. The activation of NF-κB occurs via two pathways: inflammatory cytokines, such as TNF-α and IL-1β, activate the “classical pathway”, and cytokines involved in lymph node formation, such as CD40L, activate the “alternative pathway”. NF-κB1 (p50) and NF-κB2 (p52) double-knockout mice exhibited severe osteopetrosis due to the total lack of osteoclasts, suggesting that NF-κB activation is required for osteoclast differentiation. These results indicate that NF-κB may be a therapeutic target for inflammatory bone diseases, such as rheumatoid arthritis and periodontal disease. On the other hand, mice that express the dominant negative form of IκB kinase (IKK)-β specifically in osteoblasts exhibited increased bone mass, but there was no change in osteoclast numbers. Therefore, inhibition of NF-κB is thought to promote bone formation. Taken together, the inhibition of NF-κB leads to “killing two birds with one stone”: it suppresses bone resorption and promotes bone formation. This review describes the role of NF-κB in physiological bone metabolism, pathologic bone destruction, and bone regeneration.

The Beneficial Effect of Boswellic Acid on Bone Metabolism and Possible Mechanisms of Action in Experimental Osteoporosis

“…The majority of the inflammatory effects of TNF-α are through stimulation of NF-κB [ 51 ] which has also been shown to suppress osteoblastic activity [ 52 , 53 ]. RANKL has been shown to facilitate osteoclastogenesis mediated through NF-κB signaling pathway [ 22 , 54 ].…”

Dauricine Protects from LPS-Induced Bone Loss via the ROS/PP2A/NF-κB Axis in Osteoclasts

“…A critical role of NF-κB signaling in OC differentiation has been confirmed by severe osteopetrosis in NF-κB p50/p52 double-knockout mice with defective OC differentiation [15]. In the resting state, NF-κB dimers form complexes with inhibitory IκB proteins that block the nuclear localization signal of the dimers and inhibit their nuclear localization and binding to DNA, preventing their activation [16].…”

“…Classical NF-κB signaling is initiated upon the binding of ligands to their corresponding receptors-including TNFR, RANK, and IL-1R-which activate an IKK complex containing IKKα, IKKβ, and IKKγ. The activation of IKK triggers the degradation of IκB, which in turn frees the NF-κB dimers and facilitates their nuclear translocation, leading to the DNA binding of NF-κB p50:p65 heterodimers [16]. The inactivation of IKK's catalytic activity protects against newly synthesized IκB proteins.…”

MiR-101-containing extracellular vesicles bind to BRD4 and enhance proliferation and migration of trophoblasts in preeclampsia

“…Moreover, BRD4 could bind to acetylated lysine-310, thereby modulating the nuclear factor-κB (NF-κB) transcriptional activity [13]. As a transcription factor, NF-κB could modulate genes related to inflammation and immune response [14]. In addition, the inactivation of NF-κB signaling pathway was found to be one of the underlying factors involved in attenuated placental cell injury in PE mice [15].…”